As shown in Figure 5, patients with high CHI3L2 mRNA levels correspond to shorter survival time in all glioma subgroups both in the TCGA (Figures 5A–C) and CGGA (Figures 5D–F) datasets. The gene discussed is CHI3L2; the disease is central nervous system cancer.